Use of Cephorum® Tablets 500 mg should be based on susceptibility testing and take in to account official and local antimicrobial policies. Cephorum® Tablets 500 mg should not be administered to animals which are known to be hypersensitive to cefalexin.

As with other antibiotics which are excreted mainly by the kidneys, accumulation may occur in the body when renal function is impaired. In cases of known renal insufficiency the dose should be reduced.

Hypersensitivity to cephalexin is very rare.

Symptoms of overdose include nausea, vomiting, epigastric distress, diarrhoea and haematuria. Treatment should be symptomatic.

Although laboratory and clinical studies have shown no evidence of teratogenicity, caution should be exercised when prescribing for pregnant animals. Small quantities of cefalexin are found in the milk of lactating animals.

Keep out of reach of children. For animal treatment only.

Cephalosporins may cause sensitisation (allergy) following injection, inhalation, ingestion or skin contact. Sensitivity to penicillin may lead to cross-sensitivity to cephalosporin and vice versa. Allergic reactions to these substances may occasionally be serious.

1. Do not handle this product if you know you are sensitised, or if you have been advised not to work with such preparations.

2. Handle this product with great care to avoid exposure, taking all recommended precautions.

3. If you develop symptoms following exposure such as a skin rash you should seek medical advice and show the doctor this warning. Swelling of the face, lips or eyes or difficulty breathing are more serious symptoms and require urgent medical attention.

Wash hands after use.

Summary of Products Characteristics is available on request from Forum Animal Health.